Catalyst Pharmaceuticals Announces 11th Circuit Court of Appeals Denial of Jacobus Pharmaceutical Company Inc.'s Petition for Rehearing
January 10, 2022 08:03 ET
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing,...
PetMeds® Appoints Three New Key Executives
January 10, 2022 08:00 ET
|
PetMed Express, Inc.
DELRAY BEACH, Fla., Jan. 10, 2022 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS), America's Most Trusted Pet Pharmacy®, today announced the addition of three new executives to the company....
Global Pharmaceutical Industry 2021 Highlights and What to Expect in 2022
January 10, 2022 06:18 ET
|
Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Industry Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical industry...
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
January 09, 2022 18:00 ET
|
Rapid Micro Biosystems, Inc.
Full year 2021 commercial revenue expected to be between $21.3 million and $21.7 million Full year 2022 commercial revenue outlook between $27 million and $32 million Company to Present at the 40th...
Outlook on the Enteral Nutrition Global Market to 2030 - Trend Forecast and Growth Opportunities
January 07, 2022 04:08 ET
|
Research and Markets
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Region: Trend Forecast...
Recro Reports Inducement Grants For New Staff
January 06, 2022 16:05 ET
|
Recro Pharma, Inc.
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Vaxcyte Announces FDA Clearance of Investigational New Drug Application for VAX-24 for the Prevention of Invasive Pneumococcal Disease
January 06, 2022 08:30 ET
|
Vaxcyte, Inc.
-- Company Expects to Deliver Topline Immunogenicity Results from the Phase 1/2 Clinical Study by End of 2022 -- -- VAX-24 is a 24-Valent Pneumococcal Conjugate Vaccine Candidate Designed to Provide...
Lumos Pharma to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 05, 2022 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company...
Stevia Market Worth $1.11 Billion by 2028 - Exclusive Report by Meticulous Research®
January 04, 2022 09:00 ET
|
Meticulous Market Research Pvt. Ltd.
London, Jan. 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled “Stevia Market by Type (Extract [Powder, Liquid], Leaves); Nature (Conventional, Organic); Components (Reb...
Onconova Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for...